Nvidia Bionemo News Today

Cadence Design Systems, Inc. beats earnings expectations. Reported EPS is $1.17, expectations were $1.13. Cadence Design Systems, Inc.

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.

AI-driven drug discovery is about to boom in 2024, with many announcements timed to coincide to this week's JP Morgan Healthcare conference.

Amazon Web Services and Nvidia announced Tuesday that they are partnering on new AI supercomputing initiatives as part of their strategic collaboration.

InnovationRx is your weekly digest of healthcare news. Sign up!

Roche announced on Tuesday that its biotech subsidiary Genentech has signed a multi-year AI collaboration agreement with US chipmaker Nvidia.The Swiss laboratory explains that this partnership aims to...

The acceleration of Genentech’s machine learning (ML) capabilities will take place on Nvidia’s DGX Cloud. This includes Nvidia BioNemo, which uses generative AI applications in drug discovery.

Shares of Recursion Pharmaceuticals Inc. jumped more than 4% premarket on Thursday after chip giant Nvidia Corp. on Wednesday posted blowout quarterly...

Nvidia said that DGX Cloud is designed to meet the massive supercomputing demands for training generative AI and large language models.